Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Diphenhydramine/lorazepam/zolpidem - Eusol Biotech

Next Previous
Drug Profile

Diphenhydramine/lorazepam/zolpidem - Eusol Biotech

Alternative Names: SM 1; SM1 - Eusol Biotech

Latest Information Update: 22 Oct 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Sequential Medicine Ltd
  • Developer Eusol Biotech
  • Class Acetamides; Anxiolytics; Benzodiazepines; Benzodiazepinones; Hypnosedatives; Sedating antihistamines; Sleep disorder therapies; Small molecules
  • Mechanism of Action GABA A receptor agonists; Histamine H1 receptor antagonists; Muscarinic receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase III Insomnia

Most Recent Events

  • 22 Oct 2024 Phase-III development is ongoing for Insomnia (PO) (Eusol Biotech pipeline, October 2024)
  • 31 May 2023 Sequential Medicine withdraws a phase III trial prior to enrollment, in Insomnia (NCT03338764)
  • 30 Sep 2020 No development reported - Phase-III for Insomnia in USA (PO)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top